Program
Travoprost
Also written as “Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)”, “Travoprost 0.004% / Timolol maleate 0.5%” and “Travoprost 0.004% ophthalmic solution”.
Its studies are mostly in Glaucoma, Open-Angle · Glaucoma · Glaucoma, Angle-Closure · Low Tension Glaucoma · Hydrophthalmos, led by 5 companies.
Drug pageTravoprost: every studyMany companies study it; this page follows only the 63 they lead. All 80 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Alcon | 520 open or running | phase 4since May 28, 2003 | Jan 3, 2003 | none ahead |
| Glaukosits history only | 72 open or running | phase 4since Sep 28, 2011 | Sep 28, 2011 | none ahead |
| Ocular Therapeutixits history only | 20 open or running | phase 3since Sep 21, 2016 | Dec 4, 2014 | none ahead |
| Laboratorios Sophia S.A de C.V.its history only | 10 open or running | phase 1since May 23, 2019 | May 23, 2019 | none ahead |
| Viatrisits history only | 10 open or running | phase 4since Feb 16, 2009 | Feb 16, 2009 | none ahead |
Also a collaborator on its studies: PPD DEVELOPMENT, LP.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Alcon only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 36 studies since Jan 3, 2003.
- Oct 28, 2010Phase 4 study in GlaucomaNCT01230736 · 105 enrolled · Germany
- Feb 16, 2011Phase 2 study in Glaucoma, Open-AngleNCT01298687 · 67 enrolled
- Mar 30, 2011Phase 4 study in Glaucoma, Open-AngleNCT01327599 · 60 enrolled
- Apr 14, 2011Phase 4 study in GlaucomaNCT01336569 · 50 enrolled · United States
- Oct 12, 20112 phase 3 studies in Glaucoma, Open-AngleNCT01452009, NCT01453855
- Nov 1, 2011Phase 4 study in GlaucomaNCT01464424 · 84 enrolled
- Dec 14, 2011Phase 4 study in Glaucoma, Open-AngleNCT01493427 · 202 enrolled
- Jan 11, 20122 phase 4 studies in Glaucoma, Open-AngleNCT01510145, NCT01510132
- Jul 26, 2012Phase 3 study in HydrophthalmosNCT01652664 · 184 enrolled
- Aug 3, 2012Phase 1 study in GlaucomaNCT01658839 · 25 enrolled
- Aug 10, 2012Phase 4 study in GlaucomaNCT01664039 · 104 enrolled
- Sep 27, 2012Phase 4 study in GlaucomaNCT01696383
- Nov 21, 2013Phase 4 study in Low Tension GlaucomaNCT01995136 · 32 enrolled · Japan
- Dec 2, 2013Phase 4 study in Glaucoma, Open-AngleNCT02003391 · 157 enrolled
TargetBeta
“Prostanoid FP receptor agonist”ChEMBL 37, by rule
Other programs on PTGFR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| AGN-193408 | AbbVie | phase 2 | 1 |
Studies
All 52 Alcon leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02003391Glaucoma, Open-Angle | 4 | Completed | May 2015 | 157 |
| NCT01995136Low Tension Glaucoma · Japan | 4 | Completed | Jun 2014 | 32 |
| NCT01696383Glaucoma | 4 | Withdrawn | Feb 2013 | 0 |
| NCT01664039Glaucoma | 4 | Completed | Jun 2014 | 104 |
| NCT01658839Glaucoma | 1 | Completed | Jul 2013 | 25 |
| NCT01652664Hydrophthalmos | 3 | Completed | Mar 2014 | 184 |
| NCT01510145Glaucoma, Open-Angle | 4 | Completed | May 2013 | 191 |
| NCT01510132Glaucoma, Open-Angle | 4 | Withdrawn | Jan 2012 | 0 |
| NCT01493427Glaucoma, Open-Angle | 4 | Completed | Feb 2013 | 202 |
| NCT01464424Glaucoma | 4 | Completed | Jun 2012 | 84 |
| NCT01453855Glaucoma, Open-Angle | 3 | Completed | Aug 2012 | 1,099 |
| NCT01452009Glaucoma, Open-Angle | 3 | Withdrawn | Dec 2011 | 0 |
| NCT01336569Glaucoma · United States | 4 | Completed | Mar 2012 | 50 |
| NCT01327599Glaucoma, Open-Angle | 4 | Completed | Nov 2012 | 60 |
| NCT01298687Glaucoma, Open-Angle | 2 | Completed | Apr 2011 | 67 |
| NCT01230736Glaucoma · Germany | 4 | Completed | Feb 2011 | 105 |
| NCT01114893Glaucoma, Open-Angle · United States | 2 | Completed | May 2010 | 60 |
| NCT00966940Glaucoma | 4 | Completed | Mar 2010 | 51 |
| NCT00928590Glaucoma, Open-Angle | 3 | Completed | Nov 2010 | 155 |
| NCT00872651Glaucoma, Open-Angle · China | 3 | Completed | Nov 2011 | 242 |
| NCT00848536Glaucoma, Open-Angle | 3 | Completed | Jan 2010 | 371 |
| NCT00798759Glaucoma, Open-Angle | 4 | Completed | May 2009 | 236 |
| NCT00767494Glaucoma · Belgium | 3 | Terminated | Feb 2009 | 17 |
| NCT00767481Glaucoma · Mexico | 3 | Terminated | Feb 2009 | 6 |
| NCT00763061Glaucoma · United States | 4 | Completed | Apr 2008 | 111 |
| NCT00761319Glaucoma, Open-Angle | 3 | Completed | Sep 2009 | 705 |
| NCT00762645Glaucoma, Angle-Closure | 4 | Completed | May 2008 | 30 |
| NCT00760539Glaucoma, Open-Angle · Japan | 3 | Completed | Dec 2008 | 87 |
| NCT00759239Glaucoma, Open-Angle · United Kingdom | 4 | Completed | Jan 2011 | 36 |
| NCT00758342Intraocular Pressure | 4 | Terminated | Mar 2008 | 37 |
| NCT00708422Glaucoma | 4 | Completed | Aug 2009 | 231 |
| NCT00690794Glaucoma, Open-Angle | 3 | Completed | May 2009 | 726 |
| NCT00672997Glaucoma, Open-Angle | 3 | Completed | Dec 2008 | 301 |
| NCT00670033Ocular Hypertension | 2 | Completed | Sep 2008 | 158 |
| NCT00527592Glaucoma, Open-Angle | 4 | Completed | Aug 2008 | 54 |
| NCT00527501Glaucoma, Open-Angle · United States | 2 | Completed | Dec 2007 | 136 |
| NCT00519753Glaucoma · Germany | 4 | Completed | Dec 2008 | 522 |
| NCT00508469Glaucoma, Open-Angle · Spain | 4 | Completed | Jan 2010 | 102 |
| NCT00471380Glaucoma · Italy | 4 | Completed | Oct 2008 | 46 |
| NCT00471068Glaucoma, Open-Angle · Portugal | 4 | Terminated | Aug 2008 | 46 |
| NCT00468988Glaucoma · United States | 4 | Completed | Jul 2007 | 30 |
| NCT00465803Glaucoma, Open-Angle · United States | 3 | Completed | Jan 2009 | 81 |
| NCT00444665Glaucoma · United States | 4 | Completed | Aug 2007 | 750 |
| NCT00333125Glaucoma | 3 | Completed | Feb 2007 | 319 |
| NCT00311389Glaucoma, Open-Angle · Belgium | 3 | Completed | Sep 2004 | 408 |
| NCT00293800Glaucoma, Open-Angle | 3 | Completed | Dec 2005 | 173 |
| NCT00293787Glaucoma, Open-Angle | 3 | Completed | Aug 2005 | 156 |
| NCT00288951Glaucoma, Open-Angle | 3 | Completed | Jun 2005 | 690 |
| NCT00061503Glaucoma · United States | 4 | Completed | Mar 2004 | |
| NCT00051181Glaucoma, Angle-Closure · United States, Australia | 3 | Completed | Jun 2003 | |
| NCT00051168Glaucoma, Open-Angle · United States | 3 | Completed | Mar 2009 | 502 |
| NCT00051142Glaucoma, Open-Angle · United States | 3 | Completed | Jun 2004 |
How it is read
Names in the registry
- “Travoprost”, 6 entries
- “Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)”, 5 entries
- “Travoprost 0.004% / Timolol maleate 0.5%”, 2 entries
- “Travoprost 0.004% ophthalmic solution”, 2 entries
- “Travoprost ophthalmic solution, 0.004%”, 2 entries
Conditions, from the studies’ own filings
- Glaucoma, Open-Angle, 42 studies
- Glaucoma, 20 studies
- Glaucoma, Angle-Closure, 2 studies
- Low Tension Glaucoma, 1 study
- Hydrophthalmos, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.